Differential Target Multiplexed Spinal Cord Stimulation (DTM-SCS®) Real World Outcomes

Completed

Conditions studied: Chronic Pain

In brief

The UPGRADE registry will capture long-term, real-world outcomes to understand the effect of Differential Target Multiplexed (DTM®) programming in the Spinal Cord Stimulation (SCS) implanted population on the management of chronic pain, primarily on its use for trunk and/or limb pain. The clinical study is sponsored by Celéri Health and is funded through a financial grant from Medtronic's External Research Program. The registry study will be conducted across approximately 25 centers in the United States with up to 600 participants enrolled.

Key facts

Study ID
NCT04725838
Run by
Celéri Health, Inc.
People needed
255
Starts
2021-01-29
Expected to finish
2023-07-01
Last updated by the study team
2024-08-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.